Arrowhead Moves To NASDAQ Global Market

Pasadena-based Arrowhead Research Corp., which commercializes nanotechnology products, said today that it has been upgraded to the NASDAQ Global Market, effective Friday. Arrowhead develops nanotechnology products, including anti-cancer drugs, RNAi therapeutics, electronics, and compound semiconductors, based on research it licenses from universities. Arrowhead will trade under its current symbol, ARWR.